Roflumilast Cream 0.15% in Patients with Atopic Dermatitis: Individual Patient Response from the Pooled INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials. (2024). SKIN The Journal of Cutaneous Medicine, 8(2), s372. https://doi.org/10.25251/skin.8.supp.372